IFPMA welcomes Sinovac and PowerMed to IVS task force

The International Federation of Pharmaceutical Manufacturers and Associations has welcomed the addition of China-based Sinovac Biotech and the UK's PowerMed as members of the group's Influenza Vaccine Supply international task force. In a statement, the IFPMA said that "both companies satisfy IVS membership criteria: conducting innovative influenza vaccine research, practising robust intellectual property protection and complying with GMP (Good Manufacturing Practice)." Harvey Bale, the drug industry association's director general, said: "Sinovac, the first Chinese company to join the IFPMA family, is confirmation of China's move to become a force in research-based health care."